KIFFIK BIOMEDICAL
Kiffik developed a novel technology that allows completely non-invasive access to an interstitial fluid that fits in a wearable, connected device capable of transmitting health data from nearly anywhere in the world. Kiffik Biomedical receives GHP Biotechnology award for its remarkable wearable device that offers continuous access to interstitial fluid in humans and animals.
KIFFIK BIOMEDICAL
Industry:
Biotechnology Life Science Medical Device
Founded:
2018-01-01
Address:
Providence, Rhode Island, United States
Country:
United States
Website Url:
http://www.kiffik.com
Total Employee:
1+
Status:
Active
Contact:
516-246-4000
Total Funding:
2.16 M USD
Official Site Inspections
http://www.kiffik.com Semrush global rank: 6.69 M Semrush visits lastest month: 874
- Host name: 74-208-236-124.elastic-ssl.ui-r.com
- IP address: 74.208.236.124
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kiffik Biomedical"
About – KIFFIK Biomedical Inc.
KIFFIK sees a world where diagnostics are no longer reactive, but intuitive — where listening to the body in real time becomes the foundation of preventive, personalized care for everyone. – …See details»
KIFFIK Biomedical Inc. – Visionary science. Game-changing potential
KIFFIK’s non-invasive ISF platform offers continuous or on-demand biomarker monitoring that could detect early biochemical changes associated with disease onset, progression, or …See details»
Kiffik Biomedical - Crunchbase Company Profile & Funding
Kiffik Biomedical may be growing as it has secured a strategic capital commitment of $50 million from GEM, which indicates a strong financial backing and potential for expansion. This influx …See details»
Kiffik Biomedical, Inc. | LinkedIn
KIFFIK is on a mission to transform diagnostics by unlocking the voice of the human body — providing early, non-invasive insight through interstitial fluid, and empowering people to act …See details»
Investor Center – KIFFIK Biomedical Inc.
KIFFIK’s platform is positioned to capture a meaningful share of the rapidly expanding diagnostics market and beyond, with a total addressable market (TAM) projected to reach approximately …See details»
KIFFIK Biomedical Secures Strategic $50 Million Capital …
Oct 10, 2023 KIFFIK Biomedical secures a pivotal $50 million investment from GEM Global Yield, positioning the company as a 'Unicorn-in-Waiting' and bolstering its revolutionary …See details»
Kiffik Biomedical - Contacts, Employees, Board Members
Kiffik Biomedical developed a novel technology that transmits health data.See details»
Kiffik Biomedical - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 24, 2022: Series A - Kiffik …See details»
Health monitoring: Kiffik Biomedical, Inc. is on the verge of ...
Sep 16, 2022 Abdeltif Essalik, PhD: Abdeltif Essalk is the Chief Scientific Officer of Kiffik Biomedical, Inc. Nicholas Marr: Nicholas Marr serves as the Chief Operating Officer of Kiffik …See details»
Kiffik Biomedical - BIO International Convention 2025
KIFFIK Biomedical is pioneering interstitial fluid (ISF)-based diagnostics, transforming disease detection and health monitoring with a needle-free, real-time approach. As a leader in ISF …See details»
We are excited to introduce the new KIFFIK Biomedical ... - LinkedIn
The New Frontier in Early Cancer Detection: How KIFFIK’s ISF Platform Unlocks a Molecular Advantage Kiffik Biomedical, Inc. 1mo Healthy Returns: 10 Reasons Why To Invest in Life …See details»
KIFFIK Biomedical will deliver the industry’s first noninvasive, …
Over the next 18 to 24 months, KIFFIK will enter a variety of studies including GLP and Non-GLP trials in Q1 and Q2 of 2023. KIFFIK plans on its first regulatory submission for clearance with …See details»
Powering the future of diagnostics: KIFFIK Biomedical partners …
Mar 27, 2025 KIFFIK & Rubix: advancing colorectal cancer screening with ISF and aptamer technology. While early detection is a powerful tool in the fight against colorectal cancer …See details»
KIFFIK Biomedical Secures Strategic $50 Million Capital …
Oct 10, 2023 KIFFIK Biomedical secures a pivotal $50 million investment from GEM Global Yield, positioning the company as a ‘Unicorn-in-Waiting’ and bolstering its revolutionary …See details»
News – KIFFIK Biomedical Inc.
KIFFIK Biomedical secures a pivotal $50 million investment from GEM Global Yield, positioning the company as a ‘Unicorn-in-Waiting’ KIFFIK’s patented platform will disrupt current MedTech …See details»
Kiffik is tapping interstitial fluid (ISF) for early disease detection
Jun 3, 2025 At Kiffik, we have engineered a platform called the Kiffik Lab, which collects ISF from the body without messy collection samples or puncturing of the skin. This is done through …See details»
Kiffik is on the verge of transforming the future of healthcare
Jun 14, 2023 Kiffik Biomedical is not just changing the future of health monitoring—it’s accelerating the future of healthcare. “Through strategic partnerships, we will rapidly expand …See details»
The New Frontier in Early Cancer Detection: How KIFFIK’s
Apr 17, 2025 KIFFIK has developed the first and only non-invasive device that enables continuous, lab-quality access to ISF biomarkers without the need for a blood draw, biopsy, or …See details»
Platform – KIFFIK Biomedical Inc.
KIFFIK’s non-invasive ISF platform could deliver real-time biomarker data directly at the point of injury — enabling rapid triage, injury stratification, and early detection of complications like …See details»
Resources – KIFFIK Biomedical Inc.
KIFFIK’s non-invasive ISF platform offers continuous or on-demand biomarker monitoring that could detect early biochemical changes associated with disease onset, progression, or …See details»